Eric Schiller Buys 5,000 Shares of KORU Medical Systems (NASDAQ:KRMD) Stock

KORU Medical Systems, Inc. (NASDAQ:KRMD) CTO Eric Schiller acquired 5,000 shares of the stock in a transaction on Monday, May 18th. The shares were bought at an average price of $3.91 per share, with a total value of $19,550.00. Following the purchase, the chief technology officer directly owned 5,000 shares of the company’s stock, valued at $19,550. The trade was a ∞ increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

KORU Medical Systems Trading Up 3.5%

Shares of NASDAQ:KRMD opened at $4.14 on Friday. KORU Medical Systems, Inc. has a 12-month low of $2.63 and a 12-month high of $6.61. The stock has a fifty day simple moving average of $4.19 and a two-hundred day simple moving average of $4.84. The stock has a market capitalization of $190.15 million, a price-to-earnings ratio of -82.80 and a beta of 0.43.

KORU Medical Systems (NASDAQ:KRMD) last posted its quarterly earnings results on Thursday, March 12th. The company reported ($0.01) earnings per share for the quarter, topping the consensus estimate of ($0.02) by $0.01. KORU Medical Systems had a negative return on equity of 13.61% and a negative net margin of 5.27%.The firm had revenue of $10.90 million during the quarter, compared to analysts’ expectations of $10.90 million. As a group, equities research analysts predict that KORU Medical Systems, Inc. will post -0.04 EPS for the current year.

Institutional Trading of KORU Medical Systems

Several hedge funds have recently bought and sold shares of KRMD. Simcoe Capital LLC bought a new stake in KORU Medical Systems during the fourth quarter valued at about $3,921,000. Geode Capital Management LLC grew its holdings in KORU Medical Systems by 101.3% during the second quarter. Geode Capital Management LLC now owns 997,147 shares of the company’s stock valued at $3,571,000 after purchasing an additional 501,875 shares during the period. Acuitas Investments LLC grew its holdings in KORU Medical Systems by 89.6% during the third quarter. Acuitas Investments LLC now owns 763,088 shares of the company’s stock valued at $2,923,000 after purchasing an additional 360,594 shares during the period. First Light Asset Management LLC grew its holdings in KORU Medical Systems by 5.1% during the second quarter. First Light Asset Management LLC now owns 4,681,626 shares of the company’s stock valued at $16,760,000 after purchasing an additional 226,700 shares during the period. Finally, Goldman Sachs Group Inc. grew its holdings in KORU Medical Systems by 189.5% during the first quarter. Goldman Sachs Group Inc. now owns 242,781 shares of the company’s stock valued at $617,000 after purchasing an additional 158,914 shares during the period. Institutional investors own 58.60% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the company. Wall Street Zen cut KORU Medical Systems from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. Weiss Ratings restated a “sell (d-)” rating on shares of KORU Medical Systems in a research note on Tuesday, April 21st. B. Riley Financial boosted their price target on KORU Medical Systems from $7.00 to $8.00 and gave the stock a “buy” rating in a research note on Friday, March 13th. Finally, Canaccord Genuity Group reiterated a “buy” rating and set a $6.00 price objective on shares of KORU Medical Systems in a research report on Friday, March 13th. Four investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $7.25.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products.